Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Schulz

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Pharmacogenetics|June 1, 1997
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignanciesW A Schulz, A Krummeck, I Rösinger, et al.
Anticancer Research|September 2, 1999
Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosisA G Anastasiadis, I Lemm, A Radzewitz, et al.
Urology|October 6, 2000
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinomaK H Franke, M Miklosi, P Goebell, et al.
Archives of Toxicology|December 29, 2000
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinomaC Steinhoff, K H Franke, K Golka, et al.
International Journal of Cancer|August 5, 2000
Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell typeA J Meyer, A Hernandez, A R Florl, et al.
Archives of Biochemistry and Biophysics|February 1, 1995
Efficacy of all-trans-beta-carotene, canthaxanthin, and all-trans-, 9-cis-, and 4-oxoretinoic acids in inducing differentiation of an F9 embryonal carcinoma RAR beta-lacZ reporter cell lineT Nikawa, W A Schulz, C E van den Brink, et al.
Cancer Detection and Prevention|September 4, 1998
Predictive value of molecular alterations for the prognosis of urothelial carcinomaW A Schulz, F Jankevicius, C D Gerharz, et al.
Experimental and Molecular Pathology|June 5, 2003
Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter regionA Stallmach, B M Wittig, K Kremp, et al.
Archives of Toxicology|August 26, 2000
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of associationM Steiner, M Bastian, W A Schulz, et al.
Urological Research|January 1, 1997
c-myc in bladder cancer. Clinical findings and analysis of mechanismB J Schmitz-Dräger, W A Schulz, B Jürgens, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Pharmacogenetics|June 1, 1997
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignanciesW A Schulz, A Krummeck, I Rösinger, et al.
Anticancer Research|September 2, 1999
Loss of function of the tissue specific transcription factor HNF1 alpha in renal cell carcinoma and clinical prognosisA G Anastasiadis, I Lemm, A Radzewitz, et al.
Urology|October 6, 2000
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinomaK H Franke, M Miklosi, P Goebell, et al.
Archives of Toxicology|December 29, 2000
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinomaC Steinhoff, K H Franke, K Golka, et al.
International Journal of Cancer|August 5, 2000
Novel mutations of the von hippel-lindau tumor-suppressor gene and rare DNA hypermethylation in renal-cell carcinoma cell lines of the clear-cell typeA J Meyer, A Hernandez, A R Florl, et al.
Archives of Biochemistry and Biophysics|February 1, 1995
Efficacy of all-trans-beta-carotene, canthaxanthin, and all-trans-, 9-cis-, and 4-oxoretinoic acids in inducing differentiation of an F9 embryonal carcinoma RAR beta-lacZ reporter cell lineT Nikawa, W A Schulz, C E van den Brink, et al.
Cancer Detection and Prevention|September 4, 1998
Predictive value of molecular alterations for the prognosis of urothelial carcinomaW A Schulz, F Jankevicius, C D Gerharz, et al.
Experimental and Molecular Pathology|June 5, 2003
Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter regionA Stallmach, B M Wittig, K Kremp, et al.
Archives of Toxicology|August 26, 2000
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of associationM Steiner, M Bastian, W A Schulz, et al.
Urological Research|January 1, 1997
c-myc in bladder cancer. Clinical findings and analysis of mechanismB J Schmitz-Dräger, W A Schulz, B Jürgens, et al.
Pageof 9